VX-150
VX-150 is an orally active, highly selective NaV1.8 inhibitor. VX-150 has the potential for various pain indications research[1].
Product Specifications
CAS Number
[1793080-72-4]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/vx-150.html
Purity
98.36
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C1C=C(NC(C2=CC=C(C(F)(F)F)C=C2OC3=CC=C(C=C3C)F)=O)C=CN1COP(O)(O)=O
Molecular Formula
C21H17F4N2O7P
Molecular Weight
516.34
Precautions
H302, H315, H319
References & Citations
[1]Hemme J Hijma, et al. A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adults. Pain Med. 2021 Aug 6;22 (8) :1814-1826.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
Nav1.8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
208072 100 µg
CHRNE (AchR epsilon subunit, ACHRE, Cholinergic receptor, nicotinic, epsilon, Cholinergic receptor, nicotinic, epsilon polypeptide, CMS1D, CMS1E, CMS2A, FCCMS, Nicotinic acetylcholine receptor epsilon polypeptide, SCCMS)
Ask
View Details